Nucleus Business Cash Advance Limited
Annual Report and Financial Statements
For the year ended 31 March 2024
Company Registration No. 10546776 (England and Wales)
Nucleus Business Cash Advance Limited
Company Information
Directors
C Shah
M Goldman
S Willmett
Secretary
G May
Company number
10546776
Registered office
Mezzanine Floor
St Albans House
57-59 Haymarket
London
SW1Y 4QX
Auditor
Moore Kingston Smith LLP
6th Floor
9 Appold Street
London
EC2A 2AP
Nucleus Business Cash Advance Limited
Contents
Page
Directors' report
1 - 2
Independent auditor's report
3 - 6
Profit and loss account
7
Balance sheet
8
Notes to the financial statements
10 - 13
Nucleus Business Cash Advance Limited
Directors' Report
For the year ended 31 March 2024
Page 1

The directors present their annual report and financial statements for the year ended 31 March 2024.

Principal activities

The principal activity of the company continued to be that of alternative business financing.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

C Shah
M Goldman
S Willmett
Auditor

The auditor, Moore Kingston Smith LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Nucleus Business Cash Advance Limited
Directors' Report (Continued)
For the year ended 31 March 2024
Page 2
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
S Willmett
Director
27 September 2024
Nucleus Business Cash Advance Limited
Independent Auditor's Report
To the Members of Nucleus Business Cash Advance Limited
Page 3
Opinion

We have audited the financial statements of Nucleus Business Cash Advance Limited (the 'company') for the year ended 31 March 2024 which comprise the Profit And Loss Account, the Balance Sheet, the Statement of Changes in Equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Emphasis of matter - basis of preparation

We draw attention to Note 1.2 to the financial statements which explains that the directors are no longer accepting new loan applications and currently have no intention to trade after the outstanding sums are recovered or written off. As a result, they do not consider it to be appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly the financial statements have been prepared on a basis other than going concern as described in Note 1.2. Our opinion is not modified in respect of this matter.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Nucleus Business Cash Advance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Business Cash Advance Limited
Page 4
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

Responsibilities of directors

As explained more fully in the Directors' Responsibilities Statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Nucleus Business Cash Advance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Business Cash Advance Limited
Page 5
Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

 

 

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

 

 

Nucleus Business Cash Advance Limited
Independent Auditor's Report (Continued)
To the Members of Nucleus Business Cash Advance Limited
Page 6

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the company.

Our approach was as follows:

 

 

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Ryan Day
Senior Statutory Auditor
for and on behalf of Moore Kingston Smith LLP
30 September 2024
Chartered Accountants
Statutory Auditor
6th Floor
9 Appold Street
London
EC2A 2AP
Nucleus Business Cash Advance Limited
Profit and loss account
For the year ended 31 March 2024
Page 7
2024
2023
£
£
Turnover
216,992
960,266
Cost of sales
(141,772)
(248,030)
Gross profit
75,220
712,236
Administrative expenses
(145,826)
(817,824)
Operating loss
(70,606)
(105,588)
Interest payable and similar expenses
(369,809)
(532,984)
Loss before taxation
(440,415)
(638,572)
Taxation
-
0
-
0
Loss for the financial year
(440,415)
(638,572)
Nucleus Business Cash Advance Limited
Balance Sheet
As at 31 March 2024
Page 8
2024
2023
Notes
£
£
£
£
Current assets
Debtors
4
315,957
857,711
Cash at bank and in hand
256,828
142,262
572,785
999,973
Creditors: amounts falling due within one year
5
(3,666,867)
(3,653,640)
Net current liabilities
(3,094,082)
(2,653,667)
Capital and reserves
Called up share capital
6
1,000
1,000
Profit and loss reserves
(3,095,082)
(2,654,667)
Total equity
(3,094,082)
(2,653,667)

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 27 September 2024 and are signed on its behalf by:
S Willmett
Director
Company Registration No. 10546776
Nucleus Business Cash Advance Limited
Statement of Changes in Equity
For the year ended 31 March 2024
Page 9
Share capital
Capital contribution reserve
Profit and loss reserves
Total
£
£
£
£
Balance at 1 April 2022
1,000
800,000
(2,016,095)
(1,215,095)
Year ended 31 March 2023:
Loss and total comprehensive income for the year
-
-
(638,572)
(638,572)
Other movements
-
(800,000)
-
(800,000)
Balance at 31 March 2023
1,000
-
(2,654,667)
(2,653,667)
Year ended 31 March 2024:
Loss and total comprehensive income for the year
-
-
(440,415)
(440,415)
Balance at 31 March 2024
1,000
-
(3,095,082)
(3,094,082)
Nucleus Business Cash Advance Limited
Notes to the Financial Statements
For the year ended 31 March 2024
Page 10
1
Accounting policies
Company information

Nucleus Business Cash Advance Limited is a private company limited by shares domiciled and incorporated in England and Wales. The registered office is Mezzanine Floor, St Albans House, 57-59 Haymarket, London, United Kingdom, SW1Y 4QX.

1.1
Accounting convention

These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

As at 31 March 2024, the company had net liabilities of £3,094,082true (2023: £2,653,667) and made a loss of £440,415 (2023: £638,572) for the year ended 31 March 2024. The company is a subsidiary of FC (Douglas) Limited, incorporated in Isle of Man.

 

While the company can be sustained in the short term by the loan financing available from Commercial Finance Opportunities Sub-Fund (via its 100% owned subsidiary London S.a.r.l), Nucleus Business Cash Advance Limited are no longer accepting new loan applications and currently have no intention to trade after the outstanding sums are recovered or written off. As a result, they do not consider it to be appropriate to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

Interest receivable is recognised on a monthly basis.

1.4
Cash at bank and in hand

Cash and cash equivalents include cash in hand, deposits held at call with banks and other short-term liquid investments with original maturities of three months or less.

1.5
Financial instruments

Basic financial instruments are measured at cost. The company has no other financial instruments or basic financial instruments measured at fair value.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Nucleus Business Cash Advance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2024
1
Accounting policies
(Continued)
Page 11

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Bad debt provision

The company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management considers factors including the current valuation of the assets that the company has security on, the ageing profile of debtors and historical experience. See Note 4 for the net carrying amount of the debtors, which includes an associated impairment provision of £1,226,157 (2023: £1,909,136) within trade debtors.

3
Employees

There were no persons employed directly by the company during the current or prior year.

4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
315,957
857,711
Nucleus Business Cash Advance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2024
Page 12
5
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
5,905
5,939
Other creditors
3,324,501
3,499,587
Accruals and deferred income
336,461
148,114
3,666,867
3,653,640

A third party loan balance of £3,248,000 (2023: £3,498,000) within Other creditors due within one year is secured by a fixed and floating charge over the company's assets in their entirety.

6
Called up share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
1,000 Ordinary shares of £1 each
1,000
1,000
7
Capital contribution reserve
2024
2023
£
£
At the beginning of the year
-
800,000
Repayment of capital
-
(800,000)
At the end of the year
-
-

In the prior year, the other reserve relates to a capital contribution from Nucleus Commercial Holdings Limited, the previous parent company of Nucleus Business Cash Advance Limited. Upon the sale of shares to FC (Douglas) Limited, the capital contribution was reversed and did not give rise to a realised profit.

8
Related party transactions

The company has taken advantage of the exemption available in accordance with FRS 102 section 33 'Related Party Disclosures' not to disclose transactions entered into between two or more members of a group, as the company is a wholly owned subsidiary undertaking of the group with which it is party to the transactions.

 

At 31 March 2024, there is an amount due to Nucleus Services Limited of £73,928 (2023: £nil). There is common directorship between the two companies.

Nucleus Business Cash Advance Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2024
Page 13
9
Control

The parent company is FC (Douglas) Limited, a company incorporated in the Isle of Man. The registered business address is 2nd Floor, Clarendon House, Victoria Street, Douglas, IM1 2LN.

The ultimate controlling party is C Shah, by virtue of his majority shareholdings in FC (Douglas) Limited, a company incorporated in Isle of Man.

2024-03-312023-04-01falsefalsefalseCCH SoftwareCCH Accounts Production 2024.301C ShahM GoldmanS WillmettG May0105467762023-04-012024-03-3110546776bus:Director12023-04-012024-03-3110546776bus:Director22023-04-012024-03-3110546776bus:Director32023-04-012024-03-3110546776bus:CompanySecretary12023-04-012024-03-31105467762024-03-31105467762022-04-012023-03-3110546776core:RetainedEarningsAccumulatedLosses2022-04-012023-03-3110546776core:RetainedEarningsAccumulatedLosses2023-04-012024-03-31105467762023-03-3110546776core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3110546776core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3110546776core:ShareCapital2024-03-3110546776core:ShareCapital2023-03-3110546776core:RetainedEarningsAccumulatedLosses2024-03-3110546776core:RetainedEarningsAccumulatedLosses2023-03-3110546776core:ShareCapital2022-03-3110546776core:RetainedEarningsAccumulatedLosses2022-03-3110546776core:CurrentFinancialInstruments2024-03-3110546776core:CurrentFinancialInstruments2023-03-3110546776bus:OrdinaryShareClass12023-04-012024-03-3110546776bus:OrdinaryShareClass12024-03-3110546776bus:PrivateLimitedCompanyLtd2023-04-012024-03-3110546776bus:FRS1022023-04-012024-03-3110546776bus:Audited2023-04-012024-03-3110546776bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP